Skip to main content

Table 1 4F-PCC Administration Characteristics

From: Emergency intensive care unit pharmacist’s intervention may reduce time to four-factor prothrombin complex concentrate administration: a retrospective study

No.Age (Sex)Median (IQR)Body Weight (kg)(kg, IQR)4F-PCC dose (IU/kg)Infusion time (min)IV Vitamin Kinitial PT-INRpost-4F-PCC PT-INRConsent form acquistion time (min)(min, IQR)Time from patient presentation to prescription ordering (min)Time from prescription ordering to administration (min)Type of injuryReason for administration
A77(F)74 (70–79)55.555.5 (42.1–66.4)18.08+2.201.32105103 (67–121)1055ASDHBleeding
B82(F)38.026.08+3.691.391038716Pelvic fractureBleeding
C74(M)46.254.112+11.981.4213710539CholecystitisUrgent procedures
D68(F)73.847.417+7.941.44937221SepsisUrgent procedures
E72(M)59.025.424+3.941.37411724Liver damageBleeding
F89(F)89 (67–92)43.048.0 (42.5–63.0)23.3IV+2.711.2617745 (22–128)46157ASDHBleeding
G90(M)73.024.017+3.84<1.40799574ICHBleeding
H94(F)48.025.019+2.951.15456051Traumatic pneumothoraxBleeding
I71(F)42.023.816+2.071.30103733Pelvic fractureBleeding
J63(M)53.037.7325.021.45343460Pelvic fractureBleeding
  1. 4F-PCC four factor prothrombin complex concentrate; A-E: Intervention group F-J: Nonintervention group
  2. PT-INR prothrombin time-international normalized ratio; IQR interquartile range;
  3. ASDH acute subdual hemorrhage; ICH intracranial hemorrhage; IV intravenous
\